Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.
Agnieszka PawlosMarlena BroncelEwelina WlazłowskaElżbieta JabłonowskaPaulina Gorzelak-PabiśPublished in: PloS one (2020)
The achievement of therapeutic LDLs by all recommendations is unsatisfactory, and generally worse in patients on lipid lowering therapy. Hypolipemic treatment of our HIV patients is based on low doses of statins, even in secondary prevention.